drugset / Trial / NCT01361568
Study to Evaluate Analgesic Effect of IV Administration of Kappa Agonist CR845 For Hysterectomy Surgery
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The primary purpose of this study is to determine if CR845 is effective in treating the pain associated with a laparoscopic hysterectomy.
Timeline
- Start
- 2011-07
- Primary completion
- 2012-04
- Completion
- 2012-04
Outcome
Met primary endpoint
registry Placebo-Placebo vs CR845-CR845; p <0.05; Mean Difference (Final Values) -7.96 (95% CI -15.14 to -0.78); t-test, 2 sided NCT01361568 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Difelikefalin | Protein / enzyme biologic | 0.04 mg/kg | Intravenous |
Indications
No indication recorded.